Evidence map›Paper›PMID 42231224›Full record

ArticleBMC public health2026

Lifetime cumulative effect of reproductive factors, "Life's essential 8" health status and risk of chronic kidney disease: a nationwide prospective cohort study.

Xiaoli Xu, Yuchen Xu, Yi Ding, Yuanyue Zhu, Yiping Xu, Min Xu, Yu Xu, Tiange Wang, Yuhong Chen, Shuangyuan Wang and 39 more

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors.

Xiaoli Xu *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Yuchen Xu *Shanghai Digital Medicine Innovation Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2Nd Road, Shanghai, 200025, China.
Yi Ding *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Yuanyue Zhu *Department of Geriatrics, Medical Center On Aging, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2Nd Road, Shanghai, 200025, China.
Yiping XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Min XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Yu XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Tiange WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Yuhong ChenDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Shuangyuan WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Hong LinDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Zhiyun ZhaoDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Jieli LuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Jie ZhengDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Guijun QinThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Li YanSun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Lixin ShiAffiliated Hospital of Guiyang Medical College, Guiyang, China.
Zhengnan GaoDalian Municipal Central Hospital, Dalian, China.
Lulu ChenUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tianshu ZengUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ruying HuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Zhen YeZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Xuefeng YuTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Gang ChenFujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Qing SuXinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yiming MuChinese People's Liberation Army General Hospital, Beijing, China.
Xulei TangThe First Hospital of Lanzhou University, Lanzhou, China.
Qin WanThe Affiliated Hospital of Southwest Medical University, Luzhou, China.
Guixia WangThe First Hospital of Jilin University, Changchun, China.
Yan LiuThe First Hospital of Jilin University, Changchun, China.
Feixia ShenThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zuojie LuoThe First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yingfen QinThe First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Li ChenQilu Hospital of Shandong University, Jinan, China.
Yanan HuoJiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
Qiang LiThe Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yinfei ZhangCentral Hospital of Shanghai Jiading District, Shanghai, China.
Chao LiuJiangsu Province Hospital On Integration of Chinese and Western Medicine, Nanjing, China.
Youmin WangThe First Affiliated Hospital of Anhui Medical University, Hefei, China.
Shengli WuKaramay Municipal People's Hospital, Karamay, China.
Tao YangThe First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qifu LiThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huacong DengThe First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jiajun ZhaoShandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Guang NingDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Weiqing WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China.
Weiguo HuDepartment of Geriatrics, Medical Center On Aging, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2Nd Road, Shanghai, 200025, China. wghu@rjh.com.cn.ORCID http://orcid.org/0000-0003-2156-6233
Yufang BiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China. byf10784@rjh.com.cn.ORCID http://orcid.org/0000-0002-4829-5915
Mian LiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui-Jin 2Nd Road, Shanghai, 200025, China. limian39@aliyun.com.ORCID http://orcid.org/0000-0001-6514-2729

Funding

National Key Research and Development Program of China 2023YFC2506700Science and Technology Commission of Shanghai Municipality 24DZ2307200the Innovative Research Team of High-Level Local Universities in Shanghai, and Shanghai Municipal Government 22Y31900300
6 · The paper itself

Abstract

backgroundLittle has been found regarding the lifetime cumulative effect of reproductive factors on chronic kidney disease (CKD), and how this relationship varies with cardiovascular health (CVH) remains unexplored. This study aimed to assess the relationships of lifetime cumulative estrogen exposure reflected by reproductive factors, and LE8 CVH status with incident CKD among postmenopausal women.

methodsThe study included 33,700 postmenopausal participants from the China Cardiometabolic Disease and Cancer Cohort (4 C) Study, enrolled between 2011 and 2012 with follow-up assessments conducted between 2014 and 2016 (median follow-up: 3.1 years). Lifetime cumulative estrogen exposure due to reproductive factors was evaluated through reproductive lifespan (RLS), endogenous estrogen exposure (EEE), and total estrogen exposure (TEE). Health behaviors information in Life's Essential 8 (LE8) was collected by questionnaire and laboratory examination. The risk of CKD was analyzed with Cox proportional hazards models.

resultsShorter lifetime cumulative estrogen exposure was associated with an increased risk of CKD (RLS, HR: 1.42, 95% CI: 1.19-1.70; EEE, HR: 1.39, 95% CI: 1.12-1.72; TEE, HR: 1.28, 95% CI: 1.06-1.54). Moreover, the risk decreased gradually with increasing number of optimal cardiovascular health metrics (OCVHMs). Participants with shorter duration of lifetime cumulative estrogen exposure combined with 5 or more OCVHMs no longer conferred risk for incident CKD (RLS, HR: 1.01, 95% CI: 0.70-1.47; EEE, HR: 1.15, 95% CI: 0.80-1.65; TEE, HR: 0.95, 95% CI: 0.65-1.37).

conclusionsShorter lifetime cumulative estrogen exposure was correlated with an elevated risk of CKD. It should be encouraged for postmenopausal women to preserve good CVH status for prevention of CKD.

Indexed as

EstrogensHealth StatusRenal Insufficiency, ChronicReproductive HistoryAgedCardiovascular DiseasesChinaFemaleHumansMiddle AgedPostmenopauseProspective StudiesRisk FactorsEstrogensCardiovascular healthChronic kidney diseaseCumulative estrogen exposure

Identifiers

PMID42231224
PMCPMC13647624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.